Skip to main content

Table 2 Affected organ system in cases with and without feticide and median gestational age at diagnosis

From: The impact of prenatal ultrasound screening on termination of pregnancy with and without feticide: a retrospective analysis

Structural malformation

TOP without feticide

Feticide

GA at diagnosis (median/WoP)

No major malformations (suspect/abnormal FTS* only)

116 (100.0%)

0 (0%)

14.14

Brain anomalies

132 (61,4%)

83 (38.6%)

20.86

Facial dysmorphia

18 (100%)

0 (0%)

14.64

Heart defects

96 (72.7%)

36 (27.3%)

20.21

Thoracic anomalies

15 (71.4%)

6 (28.6%)

21.00

Gastrointestinal tract anomalies

32 (82.1%)

7 (17.9%)

13.71

Urogenital tract anomalies

54 (90.0%)

6 (10%)

18.64

Skeletal dysplasia

41 (82.0%)

9 (18%)

16.86

Muscular dystrophies

4 (57.1%)

3 (42.9%)

19.00

Fetal hydrops

131 (97.0%)

4 (3%)

13.43

Spinal bifida

26 (65.0%)

14 (35.0%)

20.93

Complex malformation (> 2 major malformations)

74 (62.2%)

45 (37.8%)

19.57

Thoracophagus

5 (100.0%)

0 (0%)

12.42

Others (IUGR)

7 (87.5%)

1 (12.5%)

20.36

  1. TOP: termination of pregnancy; GA: gestational age; WoP: weeks of pregnancy; FTS: First trimester screening; IUGR: intrauterine growth restriction)
  2. *suspect or abnormal FTS: increased risk for common trisomies such as elevated nuchal translucency and abnormal hormone levels, followed by invasive testing confirming an underlying chromosomal aberration of the fetus